Kitov Pharmaceuticals Holdings Ltd (NASDAQ:KTOV) shares fell 2.3% during trading on Tuesday . The stock traded as low as $2.93 and last traded at $2.99, with a volume of 65,793 shares traded. The stock had previously closed at $3.06.

Several brokerages have commented on KTOV. Zacks Investment Research upgraded shares of Kitov Pharmaceuticals Holdings from a “hold” rating to a “buy” rating and set a $3.25 target price for the company in a report on Wednesday, July 13th. Rodman & Renshaw reiterated a “buy” rating on shares of Kitov Pharmaceuticals Holdings in a report on Monday, July 11th.

The company’s market capitalization is $11.63 million. The stock has a 50 day moving average price of $3.83 and a 200-day moving average price of $3.97.

Kitov Pharmaceuticals Holdings Ltd is an Israel-based company that develops non-steroidal anti-inflammatory drugs that treat pain without raising blood pressure, thus avoiding the increased risk of heart attacks, strokes or death.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.